Cargando…
Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries
INTRODUCTION: The impact of the COVID‐19 pandemic on the global use of anti‐dementia medication is unknown. We aimed to determine the changes of anti‐dementia medication use in Europe (EU) and North America (NA) during the pandemic. METHODS: This is a cross‐sectional study using sales data of anti‐d...
Autores principales: | Ju, Chengsheng, Lau, Wallis C.Y., Hayes, Joseph F., Osborn, David, Man, Kenneth K.C., Chan, Esther W., Wong, Ian C.K., Wei, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515555/ https://www.ncbi.nlm.nih.gov/pubmed/34692984 http://dx.doi.org/10.1002/trc2.12206 |
Ejemplares similares
-
Trazodone use and risk of dementia: A population-based cohort study
por: Brauer, Ruth, et al.
Publicado: (2019) -
Antidepressant use and risk of self-harm among people aged 40 years or older: A population-based cohort and self-controlled case series study
por: Chai, Yi, et al.
Publicado: (2022) -
Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
por: He, Ying, et al.
Publicado: (2013) -
Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study
por: Chan, Adrienne Y.L., et al.
Publicado: (2023) -
Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocol
por: Blais, Joseph E, et al.
Publicado: (2020)